Aurora-kinase inhibitors as anticancer agents

Nature Reviews Cancer

Volumn 4, Issue 12, 2004, Pages 927-936

  Keen, Nicholas ^a   Taylor, Stephen ^b  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AURORA A KINASE; AURORA B KINASE; AURORA C KINASE; AURORA KINASE INHIBITOR; CYCLOPROPANECARBOXYLIC ACID [4 [4 (4 METHYL 1 PIPERAZINYL) 6 (5 METHYL 2H PYRAZOL 3 YLAMINO) 2 PYRIMIDINYLTHIO]PHENYL]AMIDE; HESPERIDIN; N [4 [6 METHOXY 7 (3 MORPHOLINOPROPOXY) 4 QUINAZOLINYLAMINO]PHENYL]BENZAMIDE; PHOSPHOTRANSFERASE; PHOSPHOTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CARCINOGENESIS; DRUG MECHANISM; DRUG SPECIFICITY; DRUG TARGETING; GENETIC STABILITY; GENOME; HUMAN; HUMAN CELL; IN VIVO STUDY; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; REVIEW; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; ENZYME INHIBITORS; HUMANS; MITOSIS; PROTEIN-SERINE-THREONINE KINASES;

EID: 10344236486     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1502     Document Type: Review

References (52)

1. Lengauer, C., Kinzler, K.W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643-649 (1998).
2. Adams, R. R., Camnena, M. & Earnshaw, W. C. Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol. 11, 49-54 (2001).
3. Carmena, M. & Earnshaw, W. C. The cellular geography of aurora kinases. Nature Rev. Mol. Cell Biol. 4, 842-854 (2003).
4. Nigg, E. A. Mitotic kinases as regulators of cell division and its checkpoints. Nature Rev. Mol. Cell Biol. 2, 21-32 (2001).
5. Bischoff, J. R. et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17, 3052-3065 (1998). Describes the identification of the mammalian Aurora-A and -B proteins, demonstrates that both are overexpressed in human tumours and that Aurora-A is an oncogene.
6. Sen, S., Zhou, H. & White, R. A. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 14, 2195-2200 (1997).
7. Warner, S. L., Bearss, D. J., Man, H. & Von Hoff, D. D. Targeting Aurora-2 kinase in cancer. Mol. Cancer Ther. 2, 589-595 (2003).
8. Hauf, S. et al. The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J. Cell Biol. 161, 281-294 (2003). First description of Hesperadin, including a careful analysis showing how inhibition of Aurora-kinase activity in human cells results in syntelic orientation of chromosomes.
9. Ditchfield, C. et al. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J. Cell Biol. 161, 267-280 (2003). First description of ZM447439, including a careful analysis showing how inhibition of Aurora-kinase activity in human cells compromises the spindle checkpoint and induces endoreduplication in p53-deficient cells.
10. Harrington, E. A. et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nature Med. 10, 262-267 (2004). First description of VX-680, including a demonstration of the antitumour activity of an Aurora-kinase inhibitor in rodent xenograft models.
11. Hirota, T. et al. Aurora-A and an Interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell. 114, 585-598 (2003).
12. Anand, S., PenrhynLowe, S. & Venkitaraman, A. R. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 3, 51-62 (2003).
13. -/- cells. EMBO J. 21, 483-492 (2002). Many tumour cells, including ones with p53 deficiencies, have abnormal numbers of centrosomes. This paper shows that this is not necessarily because the mechanisms that control centrosome amplification are dysregulated, but because cytokinesis often fails when mitotic regulators, including Aurora-A, are overexpressed, leading to a tetraploid cell with four centrosomes.
14. Kimura, M., Matsuda, Y., Yoshioka, T. & Okano, Y. Cell cycle-dependent expression and centrosome localization of a third human aurora/Ipl1-related protein kinase, AIK3. J. Biol. Chem. 274, 7334-7340 (1999).
15. Li, X. et al. Direct association with inner centromere protein (INCENP) activates the novel chromosomal passenger protein, Aurora-C. J. Biol. Chem. 16 Aug 2004 (doi: 10.1074/jbc.M403029200).
16. Meraldi, P., Honda, R. & Nigg, E. A. Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Curr. Opin. Genet. Dev. 14, 29-36 (2004).
17. Gassmann, R. et al. Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. J. Cell Biol. 166, 179-191 (2004).
18. Gritsko, T. M. et al. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin. Cancer Res. 9, 1420-1426 (2003).
19. Katayama, H. et al. Mitotic kinase expression and colorectal cancer progression. J. Natl Cancer Inst. 91, 1160-1162 (1999).
20. Li, D. et al. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin. Cancer Res.. 9, 991-997 (2003).
21. Miyoshi, Y., Iwao, K., Egawa, C. & Noguchi, S. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int. J. Cancer 92, 370-373 (2001).
22. Sakakura, C. et al. Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br. J. Cancer 84, 824-831 (2001).
23. Sen, S. et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J. Natl Cancer Inst. 94, 1320-1329 (2002).
24. Margolis, R. L., Lohez, O. D. & Andreassen, P. R. G1 tetraploidy checkpoint and the suppression of tumorigenesis. J. Cell. Biochem. 88, 673-683 (2003).
25. Tanaka, T. U. et al. Evidence that the Ipl1-Sli15 (Aurora kinase-INCENP) complex promotes chromosome bi-orientation by altering kinetochore-spindle pole connections. Cell 108, 317-329 (2002). Demonstrates that the budding yeast Aurora kinase Ipl1 destabilizes kinetochore-microtubule interactions that do not yield tension across the centromere.
26. Nicklas, R.B. How cells get the right chromosomes. Science 275, 632-637 (1997).
27. Musacchio, A. & Hardwick, K. G. The spindle checkpoint: structural insights into dynamic signalling. Nature Rev. Mol. Cell Biol. 3, 731-741 (2002).
28. Taylor, S. S., Scott, M. I. & Holland, A. J. The spindle checkpoint: a quality control mechanism which ensures accurate chromosome segregation. Chromosome Res. 12, 599-616 (2004).
29. Biggins, S. & Murray, A. W. The budding yeast protein kinase Ipl1/Aurora allows the absence of tension to activate the spindle checkpoint. Genes Dev. 15, 3118-3129 (2001). Demonstrates that the budding yeast Aurora kinase Ipl1 activates the spindle checkpoint in the absence of tension across the centromere.
30. Roghi, C. et al. The Xenopus protein kinase pEg2 associates with the centrosome in a cell cycle-dependent manner, binds to the spindle microtubules and is involved in bipolar mitotic spindle assembly. J. Cell Sci. 111, 557-572 (1998).
31. Glover, D. M., Leibowitz, M. H., McLean, D. A. & Parry, H. Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. Cell 81, 95-105 (1995).
32. Marumoto, T. et al. Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells. J. Biol. Chem. 278, 51786-51795 (2003).
33. MurataHori, M. & Wang, Y. L. The kinase activity of aurora B is required for kinetochore-microtubule interactions during mitosis. Curr. Biol. 12, 894-899 (2002).
34. Kallio, M. J., McCleland, M. L., Stukenberg, P. T. & Gorbsky, G. J. Inhibition of aurora B kinase blocks chromosome segregation, overrides the spindle checkpoint, and perturbs microtubule dynamics in mitosis. Curr. Biol. 12, 900-905 (2002).
35. Carvalho, A., Carmena, M., Sambade, C., Earnshaw, W. C. & Wheatley, S. P. Survivin is required for stable checkpoint activation in taxol-treated HeLa cells. J. Cell Sci. 116, 14-98 (2003).
36. Lens, S. M. et al. Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension. EMBO J. 22, 2934-2947 (2003). References 35 and 36 show that repression of the Aurora-B binding partner survivin results in a similar phenotype to that induced by Hesperadin and ZM447439.
37. Johnson, V. L., Scott, M. I., Holt, S. V., Hussein, D. & Taylor, S. S. Bub1 is required for kinetochore localization of BubR1, Cenp-E, Cenp-F and Mad2, and chromosome congression. J. Cell Sci. 117, 8-89 (2004).
38. Dutertre, S. & Prigent, C. Aurora-A overexpression leads to override of the microtubule-kinetochore attachment checkpoint. Mol. Interv. 3, 127-130 (2003).
39. Adams, R. R., Maiato, H., Earnshaw, W. C. & Carmena, M. Essential roles of Drosophila inner centromere protein (INCENP) and aurora B in histone H3 phosphorylation, metaphase chromosome alignment, kinetochore disjunction, and chromosome segregation. J. Cell Biol. 153, 866-880 (2001).
40. Giet, R. & Glover, D. M. Drosophla aurora B kinase is required for histone H3 phosphorylation and condensin recruitment during chromosome condensation and to organize the central spindle during cytokinesis. J. Cell Biol. 152, 669-682 (2001).
41. Terada, Y. et al. AIM-1: a mammalian midbody-associated protein required for cytokinesis. EMBO J. 17, 667-676 (1998).
42. Hamada, M. et al. Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin's lymphoma. Br. J. Haematol. 121, 439-447 (2003).
43. Zhou, H. et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nature Genet. 20, 189-193 (1998). Reports that overexpression of Aurora-A in mouse fibroblasts induces centrosome duplication-distribution abnormalities, aneuploidy and transformation. Furthermore, overexpression of Aurora-A in human breast epithelial cells revealed similar centrosome abnormalities, as well as induction of aneuploidy.
44. EwartToland, A. et al. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nature Genet. 34, 403-412 (2003). Quantitative trait loci mapping of a locus that confers susceptibility to skin tumours in mice identifies Aurora-A. Comparative analysis of human samples identifies a polymorphism in Aurora-A.
45. Katayama, H. et al. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nature Genet. 36, 55-62 (2004).
46. Walter, A. O., Seghezzi, W., Korver, W., Sheung, J. & Lees, E. The mitotic serine/threonine kinase Aurora2/AIK is regulated by phosphorylation and degradation. Oncogene 19, 4906-4916 (2000).
47. Sitnicka, E. et al. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity 17, 463-472 (2002).
48. Mayer, T. U. et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 286, 971-974 (1999).
49. Sakowicz, R. et al. Antitumor activity of a kinesin inhibitor. Cancer Res. 64, 3276-3280 (2004).
50. Giet, R. et al. Drosophila Aurora A kinase is required to localize D-TACC to centrosomes and to regulate astral microtubules. J. Cell Biol. 156, 437-451 (2002).
51. Conte, N. et al. TACC1-chTOG-Aurora A protein complex in breast cancer. Oncogene 22, 8102-8116 (2003).
52. Delavai, B. et al. Aurora B-TACC1 protein complex in cytokinesis. Oncogene 23, 4516-4522 (2004).